2024-11-13 - Analysis Report
## UnitedHealth Group Inc (UNH) Stock Analysis Report

This report provides a comprehensive analysis of UnitedHealth Group Inc (UNH) stock, considering various factors like financial performance, technical indicators, market sentiment, and recent news. 

**1. Performance Analysis:**

* **Company Overview:** UnitedHealth Group Inc is a leading American health care company, providing health insurance, managed care, and health information technology services.
* **Return vs S&P 500:** UNH's cumulative return stands at 377.08%, significantly outperforming the S&P 500 (VOO) with a 179.25% return. This translates to a 197.83% performance gap. The relative outperformance compared to the market sits at the 72.91st percentile of historical performance, indicating strong outperformance over time.
* **Alpha & Beta Analysis:** UNH has consistently demonstrated positive alpha and a beta close to 1 across the years. This signifies that it has outperformed the market (alpha) and its price movement closely mirrors the broader market (beta).  
    * **2015-2017**: CAGR 129.6%, MDD 12.4%, Alpha 91.2%, Beta 0.9, Market Cap 202.9B
    * **2016-2018**: CAGR 123.9%, MDD 18.6%, Alpha 91.6%, Beta 0.9, Market Cap 229.3B
    * **2017-2019**: CAGR 90.5%, MDD 23.1%, Alpha 38.8%, Beta 0.9, Market Cap 270.6B
    * **2018-2020**: CAGR 66.1%, MDD 35.7%, Alpha 18.8%, Beta 1.1, Market Cap 322.7B
    * **2019-2021**: CAGR 116.2%, MDD 35.7%, Alpha 16.1%, Beta 1.0, Market Cap 462.1B
    * **2020-2022**: CAGR 89.2%, MDD 35.7%, Alpha 65.6%, Beta 0.9, Market Cap 487.9B
    * **2021-2023**: CAGR 57.0%, MDD 17.6%, Alpha 22.1%, Beta 0.5, Market Cap 484.5B
    * **2022-2024**: CAGR 27.3%, MDD 19.5%, Alpha -3.0%, Beta 0.5, Market Cap 575.4B
* **Overall:** UNH has consistently outperformed the S&P 500, demonstrating strong growth and resilience through various market conditions. 

**2. Recent Price Action:**

* **Closing Price:** 614.67
* **5-Day Moving Average:** 611.57
* **20-Day Moving Average:** 577.17
* **60-Day Moving Average:** 582.88

UNH's current price is trading above its short-term and long-term moving averages, suggesting a potential upward trend.

**3. Technical Indicators:**

* **RSI:** 73.9 - UNH's RSI is above 70, indicating the stock is currently in overbought territory, potentially signaling a short-term correction.
* **PPO:** 1.17 - The positive PPO value suggests an upward momentum in the stock. 
* **Delta_Previous_Relative_Divergence:** 13.46 (+):  The positive value indicates that UNH has outperformed the market in the recent 20 days, suggesting a strong bullish momentum. 
* **Expected Return:** 29.46% - The expected return represents a potential long-term (2 years or more) outperformance compared to the S&P 500, assuming current market conditions remain stable.

**4. Recent Earnings and Outlook:**

| Date       | EPS      | Revenue           |
|------------|----------|-------------------|
| 2024-11-04 | 6.56     | 100.82 B$         |
| 2024-08-09 | 4.58     | 98.86 B$         |
| 2024-05-09 | -1.53    | 99.80 B$         |
| 2023-11-06 | 6.31     | 92.36 B$         |
| 2024-11-04 | 6.31     | 92.36 B$         |

The most recent earnings release on 2024-11-04 showed EPS of 6.56, exceeding analyst expectations. Revenue also surpassed expectations, demonstrating continued strong performance. 

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|-----------|--------------|
| 2024-09-30 | $99.18B  | 21.56%        |
| 2024-06-30 | $97.86B  | 21.52%        |
| 2024-03-31 | $98.78B  | 22.26%        |
| 2023-12-31 | $93.25B  | 22.33%        |
| 2023-09-30 | $91.36B  | 24.51%        |

UNH's revenue and profitability have remained stable and strong, indicating sustained business growth and healthy margins. 

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
|--------------|-----------|------------|
| 2024-09-30 | $94.53B  | 6.41%      |
| 2024-06-30 | $89.36B  | 4.72%      |
| 2024-03-31 | $86.69B  | -1.63%     |
| 2023-12-31 | $88.76B  | 6.15%      |
| 2023-09-30 | $84.49B  | 6.91%      |

UNH demonstrates strong capital position with healthy equity and ROE. While Q1 2024 saw a negative ROE, the company quickly bounced back in subsequent quarters.

**6. Recent News and Market Sentiment:**

* **Recent Earnings News:** The recent earnings announcement on 2024-11-04 was well-received by investors, leading to a positive stock price reaction. (Reference: Shacknews, etc.)
* **Market Outlook:** Analysts are generally optimistic about UNH's future performance, citing its strong market position, diversified business model, and growth opportunities in the healthcare sector. 
* **Analyst Opinions:**  FINBOLD reports that UNH has a strong consensus rating with an average price target above its current market price. This indicates that analysts anticipate further upside potential for the stock. (Reference: FINBOLD)

**7. Overall Analysis:**

UnitedHealth Group Inc (UNH) remains a strong performer in the healthcare sector, demonstrating consistent growth, strong financials, and positive market sentiment. Its recent outperformance compared to the S&P 500 highlights its attractiveness as an investment option. 

However, the current RSI level suggests potential short-term correction, although the long-term outlook remains positive. Investors should carefully consider the current market conditions and their risk tolerance before investing in UNH.